Veradigm (NASDAQ:MDRX) Stock Price Down 12.2% – Here’s Why

Veradigm Inc. (NASDAQ:MDRX) fell 12.2% during mid-day trading on Friday . The company traded as low as $4.30 and last traded at $4.30. 654 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 172,133 shares. The stock had previously closed at $4.90.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a report on Saturday, March 7th.

Veradigm Stock Down 12.2%

The company has a market cap of $517.72 million, a price-to-earnings ratio of 23.25 and a beta of 0.52. The company’s 50-day moving average is $4.59 and its 200 day moving average is $4.65.

About Veradigm

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.